Writing Group Member	Employment	Research Grant	Other Research Support	Speakers’ Bureau/ Honoraria	Expert Witness	Ownership Interest	Consultant/ Advisory Board	Other
Mary Cushman	University of Vermont	None	None	None	None	None	None	None
Virginia J. Howard	University of Alabama at Birmingham	NIH-NINDS†	None	None	None	None	None	None
Monik C. Jiménez	Brigham and Women’s Hospital	NIH-NINDS†	None	None	None	None	None	Salary: Brigham and Women’s Hospital/Harvard Medical School†
Jennifer Lewey	University of Pennsylvania	None	None	None	None	None	None	None
Jean C. McSweeney	University of Arkansas for Medical Sciences	None	None	None	None	None	None	None
Lori J. Mosca	Columbia University	AHA*	None	Amarin*	None	Amarin*	Amarin*	AHA*
L. Kristin Newby	Duke University, Duke Clinical Research Institute	Boehringer Ingelheim*	None	None	None	None	None	None
Ram Poudel	American Heart Association	None	None	None	None	None	None	None
Kathryn M. Rexrode	Brigham and Women’s Hospital, Harvard Medical School	NIH†	None	None	None	None	None	None
Harmony R. Reynolds	New York University	None	None	None	None	None	None	None
Christina M. Shay	American Heart Association	None	None	None	None	None	None	None
Mario Sims	University of Mississippi	None	None	None	None	None	None	None

This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

^*

Modest.

^†

Significant.